Literature DB >> 2249838

Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis.

Y Fukuda1, M Kawamoto, A Yamamoto, M Ishizaki, F Basset, Y Masugi.   

Abstract

To study the pulmonary structural remodeling in pulmonary lymphangiomyomatosis, electron microscopy and light and electron microscopic immunohistochemical observations for elastin and alpha 1-antitrypsin were performed on five open lung biopsy samples. Lung specimens showed emphysema-like changes in areas of abnormally accumulated smooth muscle cells. In the alveolar walls having accumulated smooth muscle cells, elastic fibers were decreased in number, disrupted, granular, and occasionally accumulated. Ultrastructurally, elastic fibers in areas of smooth muscle cell accumulation showed poorly outlined amorphous components and a few microfibrils, and occasionally showed electron-dense granular deposits in and around the amorphous components. Spiraling collagen fibrils were frequently found associated with these abnormal elastic fibers. Immunohistochemistry for elastin showed even staining of amorphous components of elastic fibers in the areas of smooth muscle cell accumulation. alpha 1-Antitrypsin was also detected evenly in amorphous components of elastic fibers in the areas of smooth muscle cell accumulation. It is proposed that the emphysema-like lesions of lymphangiomyomatosis are mediated by the degradation of elastic fibers, and these degraded elastic fibers are related to an imbalance of the elastase/alpha 1-antitrypsin system similar to the probable pathogenesis of emphysema.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2249838     DOI: 10.1016/s0046-8177(06)80039-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Cystic lung disease: a comparison of cystic size, as seen on expiratory and inspiratory HRCT scans.

Authors:  K N Lee; S K Yoon; S J Choi; J M Goo; K J Nam
Journal:  Korean J Radiol       Date:  2000 Apr-Jun       Impact factor: 3.500

3.  Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis. A histological and clinicopathological study with scanning electron microscopic evaluation and element analysis.

Authors:  M Huber; W Pohl; G Reinisch; J Attems; S Pescosta; F Lintner
Journal:  Virchows Arch       Date:  2006-06-15       Impact factor: 4.064

4.  Considerations on the mechanisms of alveolar remodeling in centriacinar emphysema.

Authors:  Masuki Yamamoto; Shinobu Kunugi; Arimi Ishikawa; Yuh Fukuda
Journal:  Virchows Arch       Date:  2010-03-20       Impact factor: 4.064

5.  Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

Authors:  Connie G Glasgow; Wendy K Steagall; Angelo Taveira-Dasilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Journal:  Respir Med       Date:  2010-07       Impact factor: 3.415

6.  Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).

Authors:  Elena A Goncharova; Dmitry A Goncharov; Melane Fehrenbach; Irene Khavin; Blerina Ducka; Okio Hino; Thomas V Colby; Mervyn J Merrilees; Angela Haczku; Steven M Albelda; Vera P Krymskaya
Journal:  Sci Transl Med       Date:  2012-10-03       Impact factor: 17.956

7.  Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis.

Authors:  Chenggang Li; Xiaobo Zhou; Yang Sun; Erik Zhang; John D Mancini; Andrey Parkhitko; Tasha A Morrison; Edwin K Silverman; Elizabeth P Henske; Jane J Yu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

8.  Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis.

Authors:  Nicola Ferri; Neil O Carragher; Elaine W Raines
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; M J Hukee; S R VandenBerg; J C Charlesworth
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Authors:  Victoria Stepanova; Konstantin V Dergilev; Kelci R Holman; Yelena V Parfyonova; Zoya I Tsokolaeva; Mimi Teter; Elena N Atochina-Vasserman; Alla Volgina; Sergei V Zaitsev; Shane P Lewis; Fedor G Zabozlaev; Kseniya Obraztsova; Vera P Krymskaya; Douglas B Cines
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.